Illumina GSA-MD v3 genotyping arrays for 183 samples
Genotyping arrays for 183 samples from patients with a neuroendocrine tumor of the small intestine. All samples have been hybridized on Illumina GSA-MD v3 arrays with standard automated protocols. Reading of the chips was performed on Illumina iScan+ scanners and this file is the result of primary analysis done using Illumina GenomeStudio software. It contains data for 147 tumors, 2 adenomas, 1 lymph node, 19 mesenteric nodules, 6 liver metastasis and 8 normal ileum samples.
- 20/12/2024
- 183 samples
- DAC: EGAC50000000218
- Technology: unspecified
DUO:0000021 version: 2021-02-23
ethics approval required
This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.
ModifiersPlease provide details project synopsis for review by ethical / GDPR / Scientific Committee
DUO:0000022 version: 2021-02-23
geographical restriction
This data use modifier indicates that use is limited to within a specific geographic region.
ModifiersRestriction of use within countries enforcing a strict Patient Data / Personal Data Protection Regulation such as EU GDPR or EU approved countries
DUO:0000024 version: 2021-02-23
publication moratorium
This data use modifier indicates that requestor agrees not to publish results of studies until a specific date.
Modifiersall publications of project results involving direct or indirect use of the results must acknowledge the contribution support of : "Centre Leon Berard - CLB - Comprehensive Cancer Center, Lyon France" "Cancer Research Center of Lyon - CRCL - U1052 - UMR5286, Lyon France"
DUO:0000025 version: 2021-02-23
time limit on use
This data use modifier indicates that use is approved for a specific number of months.
Modifiers2 years maximum Exceptions possible in specific cases if approved by ethical committee
DUO:0000029 version: 2021-02-23
return to database or resource
This data use modifier indicates that the requestor must return derived/enriched data to the database/resource.
ModifiersUser shall provide a short summary report of its results to the dataset supplier for patient transparency purpose
DUO:0000044 version: 2021-02-23
population origins or ancestry research prohibited
This data use modifier indicates use for purposes of population, origin, or ancestry research is prohibited.
DUO:0000046 version: 2021-02-23
non-commercial use only
This data use modifier indicates that use of the data is limited to not-for-profit use.
Non commercial research only - GDPR compliant
Non Commercial Use only Please provide details project synopsis for review by ethical / GDPR / Scientific Committee - Prefered projects : Cancers, Digestive Diseases, Rare Diseases Restriction of use within countries enforcing a strict Patient Data / Personal Data Protection Regulation such as EU GDPR or EU approved countries 2 years maximum use - Exceptions possible in specific cases if approved by ethical committee All publications of project results involving direct or indirect use of the results must acknowledge the contribution support of : "Centre Leon Berard - CLB - Comprehensive Cancer Center, Lyon France" "Cancer Research Center of Lyon - CRCL - U1052 - UMR5286, Lyon France" User shall provide a short summary report of its results to the dataset supplier for patient transparency purpose Population origins or ancestry research prohibited
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS50000000642 | Cancer Genomics |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF50000216467 | cnv.gz | 2.5 GB |
|
|
| 1 File (2.5 GB) | ||||
